AZN Insider Trading

Insider Ownership Percentage: 0.23%
Insider Buying (Last 12 Months): £234,020
Insider Selling (Last 12 Months): GBX 0

AstraZeneca Insider Trading History Chart

This chart shows the insider buying and selling history at AstraZeneca by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AstraZeneca Share Price & Price History

Current Price: £111.02
Price Change: Price Increase of +96 (0.87%)
As of 09/29/2023 01:00 AM ET

This chart shows the closing price history over time for AZN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

AstraZeneca Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2023Michel DemareInsiderBuy2,000£117.01£234,020
12/16/2020Nazneen RahmanInsiderBuy258GBX 7,679£19,811.82
See Full Table

SEC Filings (Institutional Ownership Changes) for AstraZeneca (LON:AZN)

52.00% of AstraZeneca stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

AstraZeneca logo
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications; and collaboration with Cholesgen (Shanghai) Co.Ltd. to advance research and development in hypercholesterolemia and related metabolic diseases. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More on AstraZeneca

Today's Range

Now: £111.02
Low: £110.20
High: £112.34

50 Day Range

MA: £108.59
Low: £105.02
High: £111.96

52 Week Range

Now: £111.02
Low: 9,499.21
High: £123.92


1,571,473 shs

Average Volume

1,763,022 shs

Market Capitalization

£172.08 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of AstraZeneca?

AstraZeneca's top insider shareholders include:
  1. Michel Demare (Insider)
Learn More about top insider investors at AstraZeneca.